Latest News

Cancer Specialist Dipti Talaulikar Joins George Clinical Scientific Leadership

OVERLAND PARK, Ks., September 21, 2020 – Dipti Talaulikar, MBBS, PhD, a clinician and researcher with extensive involvement in hematology, has joined George Clinical, a global scientifically-backed clinical research organization, as a member of the organization’s scientific leadership.  In addition to her new role as a scientific leader with George Clinical, Dr. Talaulikar is also […]

Read More

September 22nd, 2020

MEDLAB and George Clinical Team up for NANABIS™ PHASE III TRIAL

Medlab Clinical, a company with a portfolio of novel drug candidates including cannabinoids and nutraceuticals, enhanced by its drug delivery platform and used for the treatment of chronic pain and disease, announced that it has signed an agreement with George Clinical to provide clinical services support for Medlab’s upcoming NanaBis™ Phase III trials. The Phase […]

Read More

September 19th, 2020

George Clinical Adds CRO Business Development and Operations Veteran to Lead Efforts in China

OVERLAND PARK, Ks., September 2, 2020 – George Clinical, a global scientifically-backed clinical research organization, has expanded the organization’s team in China with the addition of Dr. Zhenfei Yin in the role of Country Head and Regional Head of Project Operations.  Zhenfei will be responsible for leading operations teams across China. Zhenfei brings nearly a […]

Read More

September 2nd, 2020

George Clinical Scientific Leadership Adds Hypertension and Cardiovascular Researcher Professor Alta Schutte

OVERLAND PARK, Ks., August 18, 2020 – Alta Schutte, Ph.D., an expert researcher in hypertension and cardiovascular disease has joined George Clinical, a global scientifically-backed clinical research organization, as a member of the organization’s scientific leadership team. Schutte serves as Principal Theme Lead of Cardiac, Vascular and Metabolic Medicine in the faculty of medicine at […]

Read More

August 18th, 2020

George Institute Critical Care Physician Simon Finfer Receives National Recognition

Simon Finfer, professorial fellow in the Critical Care and Trauma Division at The George Institute, was recently appointed an Officer of the Order of Australia (General Division) in the Queen’s Birthday Honors list. Dr. Finfer, a critical care physician, has been working with The George Institute for 20 years and during that time has led […]

Read More

August 1st, 2020

Clinical Trial Innovations: Patient-Centric Value Added Into the Process Will Enhance the Scope and Influence of Clinical Trials for the Healthcare Community

The following article is written by George Clinical’s CMO, Maria Ali.   When outcomes are all that drive us we miss out on many important opportunities.   There has been a clear paradigm shift over the last few decades with regard to patients’ role in their medical care and treatment options. The old system whereby a […]

Read More

July 21st, 2020

Nephrologist Dr. Adrian Liew Joins George Clinical Scientific Leadership

OVERLAND PARK, Ks., June 24, 2020 – George Clinical, a global scientifically-backed clinical research organization, is pleased to announce that Dr. Adrian Liew, a national leader in Singapore and steering committee member for various global clinical trials in nephrology has joined the scientific leadership team at George Clinical. Dr. Liew is a Senior Consultant Nephrologist […]

Read More

June 24th, 2020

Subscribe to our Newsletter

  required required required required I wish to subscribe to George Clinical communications. required Yes No

Read More

June 11th, 2020

Research underscores importance of early detection of anemia, high blood pressure, and diabetes during pregnancy

There is an urgent need to raise awareness among rural women and healthcare workers at all levels of the postpartum period and the long-term health of women with a history of hypertension and gestational diabetes mellitus (GDM). Early identification and counseling of women at high risk of cardiometabolic disorders through innovative community-level interventions may offer […]

Read More

June 6th, 2020

George Clinical Commences New International COVID-19 Study Focused on Protective Measures for At-Risk Patients

OVERLAND PARK, Ks., April 30, 2020 – George Clinical, a global scientifically-backed clinical research organization, is collaborating with Saint Luke’s Mid America Heart Institute on a new study which will explore whether dapagliflozin (an SGLT inhibitor) can prevent disease progression in patients hospitalized with COVID-19 and at high risk for complications due to pre-existing cardio […]

Read More

May 1st, 2020

required
required
required
required
I wish to subscribe to George Clinical communications.
required

Add George Clinical to your network